Annual EBITDA
-$176.71 M
-$2.55 M-1.47%
September 30, 2024
Summary
- As of February 7, 2025, TWST annual EBITDA is -$176.71 million, with the most recent change of -$2.55 million (-1.47%) on September 30, 2024.
- During the last 3 years, TWST annual EBITDA has fallen by -$32.79 million (-22.79%).
- TWST annual EBITDA is now -351.78% below its all-time high of -$39.11 million, reached on September 30, 2016.
Performance
TWST EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$25.09 M
+$2.97 M+10.59%
December 31, 2024
Summary
- As of February 7, 2025, TWST quarterly EBITDA is -$25.09 million, with the most recent change of +$2.97 million (+10.59%) on December 31, 2024.
- Over the past year, TWST quarterly EBITDA has increased by +$51.99 million (+67.45%).
- TWST quarterly EBITDA is now -66.20% below its all-time high of -$15.10 million, reached on March 31, 2018.
Performance
TWST Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$167.08 M
+$9.62 M+5.45%
December 31, 2024
Summary
- As of February 7, 2025, TWST TTM EBITDA is -$167.08 million, with the most recent change of +$9.62 million (+5.45%) on December 31, 2024.
- Over the past year, TWST TTM EBITDA has increased by +$19.52 million (+10.46%).
- TWST TTM EBITDA is now -985.29% below its all-time high of -$15.39 million, reached on September 30, 2017.
Performance
TWST TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TWST EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | +67.5% | +10.5% |
| 3 y3 years | -22.8% | +52.5% | -0.6% |
| 5 y5 years | -76.8% | +53.4% | -25.6% |
TWST EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | +16.5% | at high | +67.5% | -5.9% | +21.1% |
| 5 y | 5-year | -76.8% | +16.5% | -13.9% | +67.5% | -53.5% | +21.1% |
| alltime | all time | -351.8% | +16.5% | -66.2% | +67.5% | -985.3% | +21.1% |
Twist Bioscience EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$25.09 M(-10.6%) | -$167.08 M(-5.4%) |
| Sep 2024 | -$176.71 M(+1.5%) | -$28.07 M(-63.6%) | -$176.71 M(-5.3%) |
| Jun 2024 | - | -$77.08 M(+109.2%) | -$186.60 M(+18.2%) |
| Mar 2024 | - | -$36.84 M(+6.1%) | -$157.81 M(-8.5%) |
| Dec 2023 | - | -$34.72 M(-8.6%) | -$172.41 M(-1.0%) |
| Sep 2023 | -$174.15 M(-17.7%) | -$37.96 M(-21.4%) | -$174.15 M(-4.3%) |
| Jun 2023 | - | -$48.28 M(-6.2%) | -$182.03 M(-4.2%) |
| Mar 2023 | - | -$51.45 M(+41.1%) | -$189.97 M(-2.7%) |
| Dec 2022 | - | -$36.45 M(-20.5%) | -$195.34 M(-7.7%) |
| Sep 2022 | -$211.68 M(+47.1%) | -$45.84 M(-18.5%) | -$211.68 M(+3.7%) |
| Jun 2022 | - | -$56.22 M(-1.1%) | -$204.22 M(+8.9%) |
| Mar 2022 | - | -$56.82 M(+7.6%) | -$187.60 M(+13.0%) |
| Dec 2021 | - | -$52.79 M(+37.5%) | -$166.08 M(+15.4%) |
| Sep 2021 | -$143.91 M | -$38.39 M(-3.1%) | -$143.91 M(+12.8%) |
| Jun 2021 | - | -$39.60 M(+12.2%) | -$127.55 M(+11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$35.30 M(+15.3%) | -$114.23 M(+4.9%) |
| Dec 2020 | - | -$30.63 M(+39.1%) | -$108.86 M(-17.6%) |
| Sep 2020 | -$132.09 M(+32.1%) | -$22.02 M(-16.2%) | -$132.09 M(-5.2%) |
| Jun 2020 | - | -$26.28 M(-12.2%) | -$139.35 M(+0.2%) |
| Mar 2020 | - | -$29.93 M(-44.4%) | -$139.03 M(+4.5%) |
| Dec 2019 | - | -$53.85 M(+83.8%) | -$133.04 M(+33.1%) |
| Sep 2019 | -$99.97 M(+56.3%) | -$29.29 M(+12.8%) | -$99.97 M(+12.7%) |
| Jun 2019 | - | -$25.96 M(+8.4%) | -$88.69 M(+13.3%) |
| Mar 2019 | - | -$23.95 M(+15.3%) | -$78.25 M(+12.7%) |
| Dec 2018 | - | -$20.78 M(+15.4%) | -$69.40 M(+8.5%) |
| Sep 2018 | -$63.95 M(+20.4%) | -$18.01 M(+16.1%) | -$63.95 M(+4.3%) |
| Jun 2018 | - | -$15.52 M(+2.8%) | -$61.34 M(+33.9%) |
| Mar 2018 | - | -$15.10 M(-1.5%) | -$45.82 M(+49.1%) |
| Dec 2017 | - | -$15.33 M(-0.4%) | -$30.72 M(+99.6%) |
| Sep 2017 | -$53.10 M(+35.8%) | -$15.39 M | -$15.39 M |
| Sep 2016 | -$39.11 M | - | - |
FAQ
- What is Twist Bioscience annual EBITDA?
- What is the all time high annual EBITDA for Twist Bioscience?
- What is Twist Bioscience annual EBITDA year-on-year change?
- What is Twist Bioscience quarterly EBITDA?
- What is the all time high quarterly EBITDA for Twist Bioscience?
- What is Twist Bioscience quarterly EBITDA year-on-year change?
- What is Twist Bioscience TTM EBITDA?
- What is the all time high TTM EBITDA for Twist Bioscience?
- What is Twist Bioscience TTM EBITDA year-on-year change?
What is Twist Bioscience annual EBITDA?
The current annual EBITDA of TWST is -$176.71 M
What is the all time high annual EBITDA for Twist Bioscience?
Twist Bioscience all-time high annual EBITDA is -$39.11 M
What is Twist Bioscience annual EBITDA year-on-year change?
Over the past year, TWST annual EBITDA has changed by -$2.55 M (-1.47%)
What is Twist Bioscience quarterly EBITDA?
The current quarterly EBITDA of TWST is -$25.09 M
What is the all time high quarterly EBITDA for Twist Bioscience?
Twist Bioscience all-time high quarterly EBITDA is -$15.10 M
What is Twist Bioscience quarterly EBITDA year-on-year change?
Over the past year, TWST quarterly EBITDA has changed by +$51.99 M (+67.45%)
What is Twist Bioscience TTM EBITDA?
The current TTM EBITDA of TWST is -$167.08 M
What is the all time high TTM EBITDA for Twist Bioscience?
Twist Bioscience all-time high TTM EBITDA is -$15.39 M
What is Twist Bioscience TTM EBITDA year-on-year change?
Over the past year, TWST TTM EBITDA has changed by +$19.52 M (+10.46%)